| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/23/1998 | WO1998031807A1 Novel means for the diagnosis, prevention and treatment of contamination or infections by viruses with mucous tropism |
| 07/23/1998 | WO1998031806A2 Fc RECEPTORS AND POLYPEPTIDES |
| 07/23/1998 | WO1998031805A2 Human zinc binding proteins |
| 07/23/1998 | WO1998031803A1 Therapies involving mutated heat shock transcription factor |
| 07/23/1998 | WO1998031802A2 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | WO1998031801A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 07/23/1998 | WO1998031800A2 Human proteins |
| 07/23/1998 | WO1998031799A2 Polynucleotides and polypeptides encoding receptors |
| 07/23/1998 | WO1998031798A1 Human extracellular matrix-1 |
| 07/23/1998 | WO1998031797A1 Zppar6, human tailless nuclear hormone receptor (tlx receptor) |
| 07/23/1998 | WO1998031796A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/23/1998 | WO1998031795A2 Novel human metallothionein |
| 07/23/1998 | WO1998031794A1 Vegf-binding polypeptide |
| 07/23/1998 | WO1998031793A2 Immunomodulating properties, amino acid and nucleotide sequence of colostrum derived growth factor |
| 07/23/1998 | WO1998031792A1 Hematopoietic signaling factor |
| 07/23/1998 | WO1998031788A1 Injectable formulations for treatment of osteoporotic bone |
| 07/23/1998 | WO1998031712A2 Chitosan-conjugates with acidic chelate-complex forming agents |
| 07/23/1998 | WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | WO1998031706A1 METHODS OF TREATING LUNG INFECTIONS WITH HUMAN TRACHEAL ANTIMICROBIAL PEPTIDE (hTAP) |
| 07/23/1998 | WO1998031705A1 Bromo-tryptophan conopeptides |
| 07/23/1998 | WO1998031704A2 Tachykinin antagonists |
| 07/23/1998 | WO1998031703A1 Methods for altering three-dimensional protein structure and compositions produced thereby |
| 07/23/1998 | WO1998031701A1 Endothelial pas domain protein |
| 07/23/1998 | WO1998031397A1 Treatment of diabetes with synthetic beta cells |
| 07/23/1998 | WO1998031396A1 Respiration uncoupling protein |
| 07/23/1998 | WO1998031395A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 07/23/1998 | WO1998031394A2 Tissue factor methods and compositions for coagulation and tumor treatment |
| 07/23/1998 | WO1998031392A1 Nephrotropic drugs |
| 07/23/1998 | WO1998031391A1 Obesity protein formulations |
| 07/23/1998 | WO1998031390A1 Obesity protein formulations |
| 07/23/1998 | WO1998031389A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 07/23/1998 | WO1998031386A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
| 07/23/1998 | WO1998031385A1 Enhancement of hematopoietic cells |
| 07/23/1998 | WO1998031384A1 Methods and compositions using interleukin-13 for enhancing immune responses |
| 07/23/1998 | WO1998031383A1 Modified tumor necrosis factor |
| 07/23/1998 | WO1998031381A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 07/23/1998 | WO1998031380A1 Phalloidin derivatives and analogs to treat congestive heart failure |
| 07/23/1998 | WO1998031377A1 Use of food products for protection against radicals |
| 07/23/1998 | WO1998031346A1 Preparation of particles for inhalation |
| 07/23/1998 | WO1998031324A2 Genetic alterations associated with cancer |
| 07/23/1998 | WO1998026050A3 Glutathionylspermidine synthetase |
| 07/23/1998 | WO1998025642A3 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery |
| 07/23/1998 | WO1998022493A3 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 07/23/1998 | WO1998021337A3 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
| 07/23/1998 | WO1998020906A3 Treatment of diabetes with transcription factor gene |
| 07/23/1998 | WO1998020866A3 Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists |
| 07/23/1998 | WO1998018493A3 Conjugates useful in the treatment of prostate cancer |
| 07/23/1998 | WO1998012334A3 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 07/23/1998 | WO1998012329A3 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 07/23/1998 | DE19701607A1 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung Anitkörper that bind to the nidogen-binding domain of laminin, their preparation and use |
| 07/23/1998 | DE19648232A1 Aqueous compositions containing betaine |
| 07/23/1998 | CA2403934A1 Hemotopietic signaling factor |
| 07/23/1998 | CA2403927A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2279263A1 Human zinc binding proteins |
| 07/23/1998 | CA2278811A1 Subunits of nadh dehydrogenase |
| 07/23/1998 | CA2278787A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase |
| 07/23/1998 | CA2278596A1 Novel human metallothionein |
| 07/23/1998 | CA2278477A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | CA2278349A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 07/23/1998 | CA2278248A1 Human proteins |
| 07/23/1998 | CA2278199A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
| 07/23/1998 | CA2278154A1 Fc receptors and polypeptides |
| 07/23/1998 | CA2278153A1 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | CA2278118A1 Polynucleotides and polypeptides encoding receptors |
| 07/23/1998 | CA2278102A1 Therapies involving mutated heat shock transcription factor |
| 07/23/1998 | CA2278055A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2278052A1 Hematopoietic signaling factor |
| 07/23/1998 | CA2278023A1 Modulators of insulin receptor activity |
| 07/23/1998 | CA2277869A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 07/23/1998 | CA2277816A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides |
| 07/23/1998 | CA2277793A1 Fibronectin binding protein compositions and methods of use |
| 07/23/1998 | CA2277482A1 Enhancement of hematopoietic cells |
| 07/23/1998 | CA2277282A1 Obesity protein formulations |
| 07/23/1998 | CA2276427A1 Obesity protein formulations |
| 07/23/1998 | CA2276111A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/22/1998 | EP0854193A1 Human retroviral packaging cell line |
| 07/22/1998 | EP0854192A2 Production of human cathepsin and its use |
| 07/22/1998 | EP0854191A2 Human cardiac/brain tolloid-like protein |
| 07/22/1998 | EP0854188A2 Streptococcus pneumoniae aroE polypeptides and polynucleotides |
| 07/22/1998 | EP0854186A2 Staphylococcus aureus cell division gene DivIB |
| 07/22/1998 | EP0854185A2 Assay receptor proteins and ligands |
| 07/22/1998 | EP0854150A1 Inhibition of binding of complement factor H |
| 07/22/1998 | EP0854140A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0853945A1 Liquid gonadotropin containing formulations |
| 07/22/1998 | EP0853944A2 Preparation containing proteins having thiol groups |
| 07/22/1998 | EP0853942A2 Chimeric kidney |
| 07/22/1998 | EP0853890A1 Lactose-containing food composition for infants |
| 07/22/1998 | EP0853681A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 07/22/1998 | EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 07/22/1998 | EP0853670A1 New adhesin from helicobacter pylori |
| 07/22/1998 | EP0853669A2 A gene associated with liver neoplastic disease |
| 07/22/1998 | EP0853668A2 Regulated genes and uses thereof |
| 07/22/1998 | EP0853667A2 Bone stimulating factor |
| 07/22/1998 | EP0853665A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 07/22/1998 | EP0853662A1 Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr |
| 07/22/1998 | EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 07/22/1998 | EP0853633A1 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag) |
| 07/22/1998 | EP0853629A1 Hepadnavirus receptor |
| 07/22/1998 | EP0853614A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853610A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |